New clinical paradigms for treating and preventing antiplatelet gastrointestinal bleeding

Research output: Contribution to journalReview article

1 Citation (Scopus)

Abstract

Purpose of review To quantify antiplatelet-related gastrointestinal bleeding (GIB), characterize patients at greatest risk and summarize risk-management strategies emphasizing evolving knowledge in acute management of antiplatelet-related bleeding. Recent findings New paradigms for acute management of antiplatelet-related GIB exist in the domains of resuscitation and the transfusion of blood products, strategic use of proton pump therapy and identification and eradication of Helicobacter pylori. This review will also highlight the importance of prompt resumption of cardiac aspirin and dual antiplatelet therapy following endoscopic hemostasis to minimize the risk of future cardiac events. Summary This review will provide pragmatic strategies for the management of acute antiplatelet-related GIB. Emerging areas of clinical knowledge will be addressed and knowledge gaps requiring further research to inform clinical practice will be highlighted.

Original languageEnglish (US)
Pages (from-to)467-472
Number of pages6
JournalCurrent Opinion in Gastroenterology
Volume33
Issue number6
DOIs
StatePublished - Nov 1 2017

Fingerprint

Hemorrhage
Endoscopic Hemostasis
Proton Therapy
Proton Pumps
Risk Management
Helicobacter pylori
Resuscitation
Blood Transfusion
Aspirin
Research
Therapeutics

Keywords

  • gastrointestinal hemorrhage
  • Helicobacter pylori
  • platelet
  • proton pump inhibitor
  • thienopyridine

ASJC Scopus subject areas

  • Gastroenterology

Cite this

New clinical paradigms for treating and preventing antiplatelet gastrointestinal bleeding. / Abraham, Neena Susan.

In: Current Opinion in Gastroenterology, Vol. 33, No. 6, 01.11.2017, p. 467-472.

Research output: Contribution to journalReview article

@article{61f50b847fc0447ba8d377264660107d,
title = "New clinical paradigms for treating and preventing antiplatelet gastrointestinal bleeding",
abstract = "Purpose of review To quantify antiplatelet-related gastrointestinal bleeding (GIB), characterize patients at greatest risk and summarize risk-management strategies emphasizing evolving knowledge in acute management of antiplatelet-related bleeding. Recent findings New paradigms for acute management of antiplatelet-related GIB exist in the domains of resuscitation and the transfusion of blood products, strategic use of proton pump therapy and identification and eradication of Helicobacter pylori. This review will also highlight the importance of prompt resumption of cardiac aspirin and dual antiplatelet therapy following endoscopic hemostasis to minimize the risk of future cardiac events. Summary This review will provide pragmatic strategies for the management of acute antiplatelet-related GIB. Emerging areas of clinical knowledge will be addressed and knowledge gaps requiring further research to inform clinical practice will be highlighted.",
keywords = "gastrointestinal hemorrhage, Helicobacter pylori, platelet, proton pump inhibitor, thienopyridine",
author = "Abraham, {Neena Susan}",
year = "2017",
month = "11",
day = "1",
doi = "10.1097/MOG.0000000000000394",
language = "English (US)",
volume = "33",
pages = "467--472",
journal = "Current Opinion in Gastroenterology",
issn = "0267-1379",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - New clinical paradigms for treating and preventing antiplatelet gastrointestinal bleeding

AU - Abraham, Neena Susan

PY - 2017/11/1

Y1 - 2017/11/1

N2 - Purpose of review To quantify antiplatelet-related gastrointestinal bleeding (GIB), characterize patients at greatest risk and summarize risk-management strategies emphasizing evolving knowledge in acute management of antiplatelet-related bleeding. Recent findings New paradigms for acute management of antiplatelet-related GIB exist in the domains of resuscitation and the transfusion of blood products, strategic use of proton pump therapy and identification and eradication of Helicobacter pylori. This review will also highlight the importance of prompt resumption of cardiac aspirin and dual antiplatelet therapy following endoscopic hemostasis to minimize the risk of future cardiac events. Summary This review will provide pragmatic strategies for the management of acute antiplatelet-related GIB. Emerging areas of clinical knowledge will be addressed and knowledge gaps requiring further research to inform clinical practice will be highlighted.

AB - Purpose of review To quantify antiplatelet-related gastrointestinal bleeding (GIB), characterize patients at greatest risk and summarize risk-management strategies emphasizing evolving knowledge in acute management of antiplatelet-related bleeding. Recent findings New paradigms for acute management of antiplatelet-related GIB exist in the domains of resuscitation and the transfusion of blood products, strategic use of proton pump therapy and identification and eradication of Helicobacter pylori. This review will also highlight the importance of prompt resumption of cardiac aspirin and dual antiplatelet therapy following endoscopic hemostasis to minimize the risk of future cardiac events. Summary This review will provide pragmatic strategies for the management of acute antiplatelet-related GIB. Emerging areas of clinical knowledge will be addressed and knowledge gaps requiring further research to inform clinical practice will be highlighted.

KW - gastrointestinal hemorrhage

KW - Helicobacter pylori

KW - platelet

KW - proton pump inhibitor

KW - thienopyridine

UR - http://www.scopus.com/inward/record.url?scp=85031319793&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85031319793&partnerID=8YFLogxK

U2 - 10.1097/MOG.0000000000000394

DO - 10.1097/MOG.0000000000000394

M3 - Review article

VL - 33

SP - 467

EP - 472

JO - Current Opinion in Gastroenterology

JF - Current Opinion in Gastroenterology

SN - 0267-1379

IS - 6

ER -